Japan's Taisho close to acquiring Bristol-Myers OTC unit in $1.6b deal

Taisho Pharmaceutical Holdings Co is nearing a deal to buy Bristol-Myers Squibb Co’s French over-the-counter unit, people familiar with the matter said, as the Japanese drugmaker seeks to boost its overseas presence.